Published in J Virol on June 29, 2011
Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups a and B in children in recent five consecutive years. PLoS One (2013) 1.06
Rapid spread and diversification of respiratory syncytial virus genotype ON1, Kenya. Emerg Infect Dis (2014) 0.98
Sequencing and analysis of globally obtained human respiratory syncytial virus A and B genomes. PLoS One (2015) 0.90
Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes. PLoS One (2013) 0.84
Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats. J Virol (2014) 0.81
Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific. Virol J (2012) 0.80
Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel. PLoS One (2014) 0.78
Respiratory syncytial virus epidemic periods in an equatorial city of Brazil. Influenza Other Respir Viruses (2013) 0.77
Respiratory syncytial virus genotypes circulating in urban Ghana: February to November 2006. Pan Afr Med J (2014) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol (2007) 168.76
BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13
Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol (1986) 36.06
Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med (2005) 9.47
PHYML Online--a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res (2005) 8.20
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol (2002) 5.24
The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A (1987) 4.93
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis (2008) 3.58
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis (2000) 2.68
Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr (2003) 2.38
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol (1994) 2.29
Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol (2003) 2.19
Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol (1997) 2.13
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J Gen Virol (2001) 2.09
Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev (2000) 2.07
Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication. J Virol (2006) 1.95
Molecular epidemiology of respiratory syncytial virus. Rev Med Virol (2001) 1.89
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol (2005) 1.60
Respiratory syncytial virus: reverse genetics and vaccine strategies. Virology (2002) 1.51
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J Virol (2004) 1.48
Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog (2009) 1.46
Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan. J Clin Microbiol (2009) 1.44
Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol (2007) 1.39
Molecular epidemiology of respiratory syncytial virus in Kilifi district, Kenya. J Med Virol (2004) 1.37
Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol (2001) 1.32
Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol (2005) 1.28
A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantitation of 13 respiratory viruses. J Virol Methods (2010) 1.25
Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J Clin Microbiol (1993) 1.25
Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification. J Gen Virol (1999) 1.13
A phylogenetic study of human respiratory syncytial viruses group A and B strains isolated in two cities in Japan from 1980-2002. J Med Virol (2005) 1.09
Nosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotides-duplicated G protein gene. J Med Virol (2004) 1.08
Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: Comparison of viruses and genotypes responsible for different disease manifestations. J Med Virol (2002) 1.04
Respiratory syncytial virus vaccine development. Vaccine (2001) 1.03
Respiratory syncytial virus vaccine development. Clin Lab Med (2009) 0.98
Synthetic oligonucleotide probes differentiate respiratory syncytial virus subgroups in a nucleic acid hybridization assay. J Clin Microbiol (1991) 0.98
Intrapatient variation of the respiratory syncytial virus attachment protein gene. J Virol (2010) 0.95
Molecular epidemiological analysis of a nosocomial outbreak of respiratory syncytial virus associated pneumonia in a kangaroo mother care unit in South Africa. J Med Virol (2008) 0.92
Respiratory syncytial virus bronchiolitis: clinical aspects and epidemiology. Monaldi Arch Chest Dis (1996) 0.89
Antigenic and genetic variation in human respiratory syncytial virus. Pediatr Infect Dis J (2004) 0.83
Genotypes and clinical data of respiratory syncytial virus and metapneumovirus in brazilian infants: a new perspective. Braz J Infect Dis (2009) 0.81
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Viral etiology of severe pneumonia among Kenyan infants and children. JAMA (2010) 4.41
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 3.68
Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health Organ (2005) 2.50
Global distribution of novel rhinovirus genotype. Emerg Infect Dis (2008) 2.03
Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis (2012) 1.76
Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis (2012) 1.61
Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis (2013) 1.55
Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg Infect Dis (2008) 1.48
Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis (2008) 1.36
MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis (2006) 1.35
A highly sensitive method for the detection and genotyping of West Nile virus by real-time PCR. J Virol Methods (2009) 1.22
Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza Other Respir Viruses (2011) 1.19
Rapid molecular strategy for filovirus detection and characterization. J Clin Microbiol (2006) 1.18
Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis (2013) 1.18
Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009. Clin Infect Dis (2014) 1.07
Shuni virus as cause of neurologic disease in horses. Emerg Infect Dis (2012) 1.05
Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis (2013) 1.04
Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis (2013) 0.97
Isolation of tick and mosquito-borne arboviruses from ticks sampled from livestock and wild animal hosts in Ijara District, Kenya. Vector Borne Zoonotic Dis (2013) 0.97
HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis (2013) 0.96
Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis (2014) 0.96
Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial. AIDS (2013) 0.95
Seroprevalence of Crimean Congo hemorrhagic fever virus in Ijara District, Kenya. Vector Borne Zoonotic Dis (2012) 0.93
Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses (2015) 0.93
Cytokine induction after laboratory-acquired West Nile virus infection. N Engl J Med (2009) 0.93
Respiratory syncytial virus associated illness in high-risk children and national characterisation of the circulating virus genotype in South Africa. J Clin Virol (2003) 0.92
Molecular epidemiological analysis of a nosocomial outbreak of respiratory syncytial virus associated pneumonia in a kangaroo mother care unit in South Africa. J Med Virol (2008) 0.92
Transmission of West Nile virus during horse autopsy. Emerg Infect Dis (2010) 0.90
Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J (2015) 0.90
West Nile virus neurologic disease in humans, South Africa, September 2008-may 2009. Emerg Infect Dis (2012) 0.90
Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa. Virus Genes (2005) 0.87
Prospective cohort study comparing seasonal and H1N1(2009) pandemic influenza virus illnesses in HIV-infected children during 2009. Pediatr Infect Dis J (2014) 0.86
Pathology of fatal lineage 1 and 2 West Nile virus infections in horses in South Africa. J S Afr Vet Assoc (2014) 0.85
Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. Emerg Infect Dis (2013) 0.85
Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis (2015) 0.82
Antibodies against West Nile and Shuni Viruses in Veterinarians, South Africa. Emerg Infect Dis (2014) 0.81
Genomic and phylogenetic characterization of Shuni virus. Arch Virol (2014) 0.81
Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses (2014) 0.77
Sindbis and Middelburg Old World Alphaviruses Associated with Neurologic Disease in Horses, South Africa. Emerg Infect Dis (2015) 0.75
Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. Emerg Infect Dis (2017) 0.75
Serum neutralising antibody response of seronegative horses against lineage 1 and lineage 2 West Nile virus following vaccination with an inactivated lineage 1 West Nile virus vaccine. J S Afr Vet Assoc (2013) 0.75
West Nile Virus Lineage 2 in Horses and Other Animals with Neurologic Disease, South Africa, 2008-2015. Emerg Infect Dis (2017) 0.75